Progyny Inc (NAS:PGNY)
$ 26.31 +0.63 (+2.45%) Market Cap: 2.02 Bil Enterprise Value: 1.80 Bil PE Ratio: 28.60 PB Ratio: 4.49 GF Score: 93/100

Q2 2025 Progyny Inc Earnings Call Transcript

Aug 7, 2025 / 08:45 PM GMT
Release Date Price: $23.06 (-1.83%)

Key Points

Positve
  • Progyny Inc (PGNY) reported a strong second quarter with record revenue and adjusted EBITDA, demonstrating solid growth and financial performance.
  • The company raised its full-year guidance, reflecting confidence in continued strong performance and market demand.
  • Progyny Inc (PGNY) successfully expanded its client base, with over 550 clients and nearly 6.8 million covered lives, showcasing its ability to attract and retain clients.
  • The integration of recent acquisitions, such as Benefit Bump, has been completed, enhancing Progyny Inc (PGNY)'s product offerings and contributing positively to sales.
  • Progyny Inc (PGNY) formed a new partnership with Amazon, becoming the first women's health solution in their Health Benefits connector program, which could drive future enrollment and awareness.
Negative
  • The company experienced slower initial pipeline growth earlier in the year, which could impact the timing of sales and client acquisitions.
  • Revenue growth from Progyny RX was slower in the first half compared to the fertility benefits business, indicating potential variability in product performance.
  • The demographic differences in new client acquisitions resulted in lower covered lives compared to the previous year, which could affect overall growth metrics.
  • Progyny Inc (PGNY) faces potential risks from macroeconomic uncertainties and industry-specific challenges that could impact client decision-making and sales cycles.
  • The company is making significant investments in product platform expansion and acquisition integration, which could pressure margins and profitability in the short term.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PGNY.OQ - Progyny Inc
Q2 2025 Progyny Inc Earnings Call
Aug 07, 2025 / 08:45PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thanks for holding. We appreciate your time and patience. Please stay on the line and we'll be back in just a moment.

Thank you for.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Holding. We sincerely.

Good day everyone. Welcome to the Progeny Inc. 2nd quarter 2025 earnings call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for your questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, James Hart. The floor is yours.

-------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot